Unveiling a new factor that helps breast cancer cells to tolerate drugs


Among the different types of Breast Cancer, endocrine receptor-positive (ER+) is the most common one. For many years, scientists failed to explain how ER+ cells can adapt and tolerate the drugs, especially in post-menopausal stage. Japanese group, led by Professor Mitsuyoshi Nakao and Professor Noriko Saitoh at Kumamoto University, has recently published a research article in Nature Communications journal that helps to explain the adaptation process.